How antibody therapy affects the breadth of COVID mRNA vaccines


Nearly three years into the pandemic, many of us now carry antibodies against the virus—due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influence the character of our body’s response to SARS-CoV-2.

Meet the (protein) neighbors: New method lets researchers detect proteins in close proximity in single cells

Previous article

Postpartum diabetes testing low for women with gestational diabetes

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations